Qian J - Search Results

1

Effect of miR-23 on oxidant-induced injury in human retinal pigment epithelial cells.

Lin H, Qian J, Castillo AC, Long B, Keyes KT, Chen G, Ye Y. Lin H, et al. Among authors: qian j. Invest Ophthalmol Vis Sci. 2011 Aug 9;52(9):6308-14. doi: 10.1167/iovs.10-6632. Invest Ophthalmol Vis Sci. 2011. PMID: 21693609

2

Impact of HMG-CoA reductase inhibition on oxidant-induced injury in human retinal pigment epithelium cells.

Qian J, Keyes KT, Long B, Chen G, Ye Y. Qian J, et al. J Cell Biochem. 2011 Sep;112(9):2480-9. doi: 10.1002/jcb.23173. J Cell Biochem. 2011. PMID: 21544860

3

Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-γ-independent manner.

Birnbaum Y, Long B, Qian J, Perez-Polo JR, Ye Y. Birnbaum Y, et al. Among authors: qian j. Basic Res Cardiol. 2011 May;106(3):431-46. doi: 10.1007/s00395-011-0162-3. Epub 2011 Mar 1. Basic Res Cardiol. 2011. PMID: 21360043

4

Regulation of phosphatase and tensin homolog on chromosome 10 in response to hypoxia.

Qian J, Ling S, Castillo AC, Long B, Birnbaum Y, Ye Y. Qian J, et al. Am J Physiol Heart Circ Physiol. 2012 May 1;302(9):H1806-17. doi: 10.1152/ajpheart.00929.2011. Epub 2012 Feb 24. Am J Physiol Heart Circ Physiol. 2012. PMID: 22367504 Free article.

5

Modulation of microRNAs in hypertension-induced arterial remodeling through the β1 and β3-adrenoreceptor pathways.

Ling S, Nanhwan M, Qian J, Kodakandla M, Castillo AC, Thomas B, Liu H, Ye Y. Ling S, et al. Among authors: qian j. J Mol Cell Cardiol. 2013 Dec;65:127-36. doi: 10.1016/j.yjmcc.2013.10.003. Epub 2013 Oct 24. J Mol Cell Cardiol. 2013. PMID: 24161401

6

The role of microRNA in modulating myocardial ischemia-reperfusion injury.

Ye Y, Perez-Polo JR, Qian J, Birnbaum Y. Ye Y, et al. Among authors: qian j. Physiol Genomics. 2011 May 1;43(10):534-42. doi: 10.1152/physiolgenomics.00130.2010. Epub 2010 Oct 19. Physiol Genomics. 2011. PMID: 20959496 Review.

7

Aliskiren and Valsartan reduce myocardial AT1 receptor expression and limit myocardial infarct size in diabetic mice.

Ye Y, Qian J, Castillo AC, Perez-Polo JR, Birnbaum Y. Ye Y, et al. Among authors: qian j. Cardiovasc Drugs Ther. 2011 Dec;25(6):505-15. doi: 10.1007/s10557-011-6339-z. Cardiovasc Drugs Ther. 2011. PMID: 21987107

8

Phosphodiesterase III inhibition increases cAMP levels and augments the infarct size limiting effect of a DPP-4 inhibitor in mice with type-2 diabetes mellitus.

Birnbaum Y, Castillo AC, Qian J, Ling S, Ye H, Perez-Polo JR, Bajaj M, Ye Y. Birnbaum Y, et al. Among authors: qian j. Cardiovasc Drugs Ther. 2012 Dec;26(6):445-56. doi: 10.1007/s10557-012-6409-x. Cardiovasc Drugs Ther. 2012. PMID: 22936458

9

Phosphodiesterase-3 inhibition augments the myocardial infarct size-limiting effects of exenatide in mice with type 2 diabetes.

Ye Y, Qian J, Castillo AC, Ling S, Ye H, Perez-Polo JR, Bajaj M, Birnbaum Y. Ye Y, et al. Among authors: qian j. Am J Physiol Heart Circ Physiol. 2013 Jan 1;304(1):H131-41. doi: 10.1152/ajpheart.00609.2012. Epub 2012 Oct 26. Am J Physiol Heart Circ Physiol. 2013. PMID: 23103492 Free article.

10

Aleglitazar, a dual peroxisome proliferator-activated receptor-α and -γ agonist, protects cardiomyocytes against the adverse effects of hyperglycaemia.

Chen Y, Chen H, Birnbaum Y, Nanhwan MK, Bajaj M, Ye Y, Qian J. Chen Y, et al. Among authors: qian j. Diab Vasc Dis Res. 2017 Mar;14(2):152-162. doi: 10.1177/1479164116679081. Epub 2017 Jan 23. Diab Vasc Dis Res. 2017. PMID: 28111985 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,820 results

Search Page

Filters